Related Experiment Video
Updated: Feb 2, 2026

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
Comorbidities and Consequences in Hospitalized Heart Failure Patients with Depression
Rikinkumar S Patel1, Shristi Shrestha2, Hina Saeed3
1Department of Psychiatry, Griffin Memorial Hospital, Norman, USA.
Insights
Middle-aged white females with heart failure are more likely to have major depressive disorder (MDD). Comorbid depression in heart failure patients, especially with hypothyroidism, increases hospitalization duration, costs, and mortality risk.
Area of Science:
- Cardiology and Psychiatry
- Health Services Research
Background:
- Major depressive disorder (MDD) is a significant comorbidity in patients with congestive heart failure (CHF).
- Understanding demographic predictors and outcomes associated with MDD in hospitalized CHF patients is crucial for improving care.
Purpose of the Study:
- To identify demographic predictors of MDD in hospitalized CHF patients.
- To analyze differences in hospital stay, cost, and in-hospital mortality associated with MDD and its comorbidities in CHF patients.
Main Methods:
- Retrospective cross-sectional study utilizing nationwide inpatient data from the Healthcare Cost and Utilization Project (HCUP).
- Identified CHF patients with and without MDD using ICD-9-CM codes.
- Chi-square tests and logistic regression models were employed to analyze comorbidities and mortality risk.
Main Results:
- Elderly, middle-aged (36-50 years), white, and female CHF patients showed a higher likelihood of co-diagnosed MDD.
- Hypothyroidism and drug abuse were more prevalent in depressed CHF patients.
- Hypothyroidism was linked to longer stays, higher costs, and increased mortality risk; alcohol abuse also elevated mortality risk.
Conclusions:
- Middle-aged white females with comorbid depression face higher risks in CHF hospitalizations.
- Depressed CHF patients with hypothyroidism experience worse outcomes, including longer stays, higher costs, and increased mortality.
- Integrated healthcare models are needed for early MDD diagnosis and treatment in CHF patients to reduce mortality and enhance outcomes.
Abstract:
Objective To evaluate the demographic predictors of major depressive disorder (MDD) in hospitalized congestive heart failure (CHF) patients and measure the differences in hospital stay and cost per comorbidities and the associated risk of in-hospital mortality. Methods This retrospective cross-sectional study used nationwide inpatient data from the healthcare cost and utilization project (HCUP). We identified patients with CHF as the primary diagnosis and MDD as the secondary diagnosis using ICD-9-CM codes and compared with the CHF patient without MDD. The differences in comorbidities were quantified using chi-square tests and the logistic regression model was used to evaluate mortality risk among comorbidities using odds ratio (OR). Results Elder CHF patients, 36-50-year-old (OR: 1.324) and whites (OR: 1.673), have a higher likelihood of a co-diagnosis of MDD. Females with heart failure have two-fold higher odds of MDD (OR: 2.332). Majority of the medical comorbidities were seen in a higher proportion of CHF patients without MDD. Hypothyroidism (10.2%) and drug abuse (15.2%) were seen more in depressed patients comparatively. Among substance use disorder, patients with drug abuse stayed longer and had a higher hospitalization total cost ($51,828). And, hypothyroidism was associated with longer inpatient stay (5.6 days) and cost ($64,726), and four-fold higher odds of in-hospital mortality (OR: 4.405). Though alcohol abuse was seen only in 7.4% of CHF patients with MDD, it was associated with the three-fold higher likelihood of deaths during hospitalization (OR: 3.195). Conclusion A middle-aged, white female with comorbid depression has a higher risk of hospitalization for heart failure. Depressed CHF patients with comorbid hypothyroidism were hospitalized for a longer duration with higher inpatient cost and four times higher risk of mortality during hospitalization stay. Further studies are required to evaluate the underlying cause of worse hospital outcomes in depressed CHF patients with alcohol abuse and hypothyroidism. An integrated healthcare model is required for early diagnosis and treatment of depression and associated comorbidities in CHF patients to reduce mortality and improve post-CHF outcomes.
More Related Videos
04:20Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
Published on: October 1, 2019
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
Related Concept Videos
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Hospitals-II
Nurses that work in...
Heart Failure VI: Adjunct Therapies
Heart Failure Drugs: Diuretics